(MENAFN) Affymetrix, the American company that manufactures DNA microarrays and advanced genetic analysis technology, turned down a purchase bid of USD1.5 billion, according to the latest reports.
Accordingly, company officials has declared that the USD1.5 billion offer by some of its former employees, who have set up a shell firm named Origin Technologies, was not intriguing at all.
Meanwhile, Affymetrix agreed in January to sell itself to Thermo Fisher for USD14 a share, but Origin, which is linked to Centrillion Technology Holdings, proposed paying USD16.10 a share in cash.
Thermo Fisher, the US biotechnology product development firm, has put out its own response, raising questions about Origin's financing and playing up concerns about whether the government would approve the new offer.
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.